Cytopathogenic Effect, Viral
"Cytopathogenic Effect, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.
| Descriptor ID |
D003588
|
| MeSH Number(s) |
E01.370.225.500.384.235 E05.200.500.384.235 E05.242.384.235 G06.920.190
|
| Concept/Terms |
Cytopathogenic Effect, Viral- Cytopathogenic Effect, Viral
- Cytopathic Effect, Viral
- Cytopathic Effects, Viral
- Effect, Viral Cytopathic
- Effects, Viral Cytopathic
- Viral Cytopathic Effect
- Viral Cytopathic Effects
- Viral Cytopathogenic Effect
- Cytopathogenic Effects, Viral
- Effect, Viral Cytopathogenic
- Effects, Viral Cytopathogenic
- Viral Cytopathogenic Effects
|
Below are MeSH descriptors whose meaning is more general than "Cytopathogenic Effect, Viral".
Below are MeSH descriptors whose meaning is more specific than "Cytopathogenic Effect, Viral".
This graph shows the total number of publications written about "Cytopathogenic Effect, Viral" by people in this website by year, and whether "Cytopathogenic Effect, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytopathogenic Effect, Viral" by people in Profiles.
-
Becerra-Artiles A, Santoro T, Stern LJ. Evaluation of a method to measure HHV-6B infection in?vitro based on cell size. Virol J. 2018 01 05; 15(1):4.
-
Savidis G, Perreira JM, Portmann JM, Meraner P, Guo Z, Green S, Brass AL. The IFITMs Inhibit Zika Virus Replication. Cell Rep. 2016 06 14; 15(11):2323-30.
-
Bobst CE, Abzalimov RR, Houde D, Kloczewiak M, Mhatre R, Berkowitz SA, Kaltashov IA. Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches. Anal Chem. 2008 Oct 01; 80(19):7473-81.
-
Ali SH, Chandraker A, DeCaprio JA. Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones. Antivir Ther. 2007; 12(1):1-6.
-
Wang S, Chou TH, Sakhatskyy PV, Huang S, Lawrence JM, Cao H, Huang X, Lu S. Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system. J Virol. 2005 Feb; 79(3):1906-10.
-
Schmidt B, Scott I, Whitmore RG, Foster H, Fujimura S, Schmitz J, Levy JA. Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation. Virology. 2004 Nov 24; 329(2):280-8.
-
Somasundaran M, Sharkey M, Brichacek B, Luzuriaga K, Emerman M, Sullivan JL, Stevenson M. Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci U S A. 2002 Jul 09; 99(14):9503-8.
-
Soderberg K, Denekamp L, Nikiforow S, Sautter K, Desrosiers RC, Alexander L. A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase. J Virol. 2002 Jun; 76(11):5803-6.
-
Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, Gauntt CJ, Liu PP. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology. 2000 May 25; 271(1):99-108.
-
Desrosiers RC, Sasseville VG, Czajak SC, Zhang X, Mansfield KG, Kaur A, Johnson RP, Lackner AA, Jung JU. A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol. 1997 Dec; 71(12):9764-9.